Study title:
Susceptibility of 1034 Streptococcus
pneumoniae and 1039 Streptococcus
pyogenes strains from paediatric patients
in ten central and eastern European
contries to telithromycin, erythromycin A,
azithromycin, clarithromycin, clindamycin,
levofloxacin, quinupristin/dalfopristin, and
penicillin G
Type of medicine: Centrally authorised medicines
|
Therapeutic area: Bacterial Infections and Mycoses
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: telithromycin |
ATC code: J01FA15 |
Document link:
|
Document date:
|
Study number: USA-00-647-657 |
EudraCT number:
|
Scope of study: CLINICAL |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
-
|
-
|